Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”

Detalles Bibliográficos
Autores principales: Hollenack, Kelly, Marshall, Jade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009776/
https://www.ncbi.nlm.nih.gov/pubmed/33674999
http://dx.doi.org/10.1007/s40273-021-01005-w
_version_ 1783672941142081536
author Hollenack, Kelly
Marshall, Jade
author_facet Hollenack, Kelly
Marshall, Jade
author_sort Hollenack, Kelly
collection PubMed
description
format Online
Article
Text
id pubmed-8009776
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80097762021-04-16 Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome” Hollenack, Kelly Marshall, Jade Pharmacoeconomics Letter to the Editor Springer International Publishing 2021-03-06 2021 /pmc/articles/PMC8009776/ /pubmed/33674999 http://dx.doi.org/10.1007/s40273-021-01005-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Letter to the Editor
Hollenack, Kelly
Marshall, Jade
Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
title Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
title_full Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
title_fullStr Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
title_full_unstemmed Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
title_short Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
title_sort comment on “cost-effectiveness of cannabidiol adjunct therapy versus usual care for the treatment of seizures in lennox-gastaut syndrome”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009776/
https://www.ncbi.nlm.nih.gov/pubmed/33674999
http://dx.doi.org/10.1007/s40273-021-01005-w
work_keys_str_mv AT hollenackkelly commentoncosteffectivenessofcannabidioladjuncttherapyversususualcareforthetreatmentofseizuresinlennoxgastautsyndrome
AT marshalljade commentoncosteffectivenessofcannabidioladjuncttherapyversususualcareforthetreatmentofseizuresinlennoxgastautsyndrome

Ejemplares similares